The Anticoagulation CPA, a 4.6 INR, and a Note That Says "Notified"

Partly clinical judgment, largely outside the agreement - and the documentation is indefensible.

Scope analysis: the CPA authorizes adjustment within INR 2.0–3.0. At 4.6 the pharmacist's authority converts from "adjust" to "notify and obtain direction." Holding two doses is a therapy change. Without prescriber direction, holding exceeded the four corners of the CPA. The clinically sound instinct (a 4.6 INR plus a newly started TMP-SMX, which inhibits warfarin metabolism and raises INR, in a 78-year-old at bleeding risk) does not create authority; authority comes from the document or from the prescriber.

What was permissible: recognizing the emergency, taking a reasonable interim safety step to prevent hemorrhage, and escalating. What was required: exhausting actual contact routes - the covering physician, the on-call list, the clinic's after-hours number, the patient's other prescriber, and, if the CPA contains a contingency provision, following it exactly. If no clinician can be reached and the risk is immediate, the correct step is to direct the patient to urgent/emergency care rather than to manage alone.

The far worse problem: the note states the prescriber was notified when she was not. That is falsification of a patient record, independent of whether the clinical decision was reasonable.

Characterization: Utah's unprofessional conduct statutes for health professions and for pharmacy reach conduct including practicing outside the scope of one's license or agreement, failing to maintain adequate records, falsifying or altering patient records, gross or repeated negligence, and violating laws governing the practice. The note is the center of gravity: an inaccurate entry asserting prescriber contact that never occurred compromises every downstream decision. The clinical management outside the CPA is a separate, lesser theory, but it will be pleaded alongside the record issue.

PIC's obligations, in order:

1. Patient safety first - confirm the patient's current status, ensure the family and treating clinicians have accurate information, and correct the record with a clearly identified addendum (never by deleting or overwriting the original entry).
2. Preserve evidence - original record, audit trail, phone logs, scheduling records, the CPA itself, and the pharmacist's statement.
3. Internal review - was this a system failure (no after-hours coverage in the CPA, no escalation protocol) as well as an individual failure? Fix the CPA, add a covering-prescriber requirement, and require documentation of contact attempts.
4. Reporting - determine whether Utah requires a report to DOPL for this event (check the mandatory-reporting provisions rather than guessing); a falsified record is the type of matter most employers and many states treat as reportable, and the PIC should consult counsel and the Board's rules before concluding no report is required.
5. Disclosure to the patient/family - HIPAA permits disclosure of protected health information for treatment and quality purposes, and an honest explanation of what happened is both ethically expected and risk-reducing.
6. Personnel action consistent with employment law, separate from any licensing consequence.

Typical path:

1. Complaint intake - a complaint is filed by a patient, employer, colleague, or on the Division's own initiative (an inspection finding can start one).
2. Investigation - DOPL investigators gather records and interview the licensee, who is entitled to respond; the licensee must cooperate, and failure to cooperate is itself a basis for discipline.
3. Board review / probable cause - the Board of Pharmacy reviews the investigative file and determines whether probable cause exists to proceed.
4. Resolution - the case may be closed, resolved by a stipulation and order (often with a reprimand, fine,CE, monitoring, or practice restrictions), or proceed to formal adjudication.
5. Formal proceeding - a notice of agency action initiates an adjudicative proceeding under Utah's administrative procedures framework; a hearing is held before an administrative law judge or hearing officer, the Board reviews and recommends, and the Division Director issues the final order. Emergency action to suspend or restrict a license is available where continued practice presents an imminent risk.
6. Appeal - rehearing and judicial review are available.

Range of sanctions: dismissal, letter of reprimand, administrative fine, remedial education, practice restrictions or limitations, probation with monitoring, suspension (stayed or actual), and revocation. Criminal exposure is separate; the Board's authority is over the license, but conduct can be referred for prosecution.

Practical point for the PIC: the pharmacy's own license and the PIC's supervision obligations will be examined in the same investigation - an inspector will look at whether the CPA was properly documented, whether after-hours coverage existed, and whether the pharmacy's quality program caught the problem. The institutional response is part of the defense.